Skip to content

Ringerfundin in perioperative clinical application research of liver ischemia/reperfusion protection

Ringerfundin in perioperative clinical application research of liver ischemia/reperfusion protection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011224
Enrollment
Unknown
Registered
2017-04-23
Start date
2017-05-01
Completion date
Unknown
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver resection Anesthesia

Interventions

acetate group:Salinger acetate solution15ml/kg
Malic acid group:Malic acid acetic acid fluid of salinger15ml/kg

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: patients who were scheduled to undergo Liver resection surgery due to focal liver lesions, and whose condition corresponded to physical status I and II of the American Society of Anesthesiologists(ASA), aged 18 to 70 years

Exclusion criteria

Exclusion criteria: Exclusion criteria included coagulation deficiency,hepatic dysfunction,Severe systemic disease.

Design outcomes

Primary

MeasureTime frame
ICG PDR;R15;aminopherase;

Countries

China

Contacts

Public ContactHaitao Xu

Department of Anesthesiology, Shanghai Changzheng Hospital

xu_tt@163.com+86 13761881357

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026